Table 2.
Follow‐up data of INOCA patients with no‐stenosis (0% stenosis), nonobstructive stenosis (0% < stenosis < 50%), no‐CMD, and CMD.
| No‐stenosis (n = 71) | Nonobstructive stenosis (n = 80) | p Value | |
|---|---|---|---|
| MACE, n (%) | 26 (36.6) | 20 (25.0) | 0.122 |
| CMD, n (%) | 25 (46.3) | 13 (33.3) | |
| No‐CMD, n (%) | 1 (5.9) | 7 (17.1) | |
| p‐value | 0.003 | 0.093 | |
| Cardiovascular death, n (%) | 1 (1.4) | 1 (1.3) | 1.000 |
| Nonfatal MI, n (%) | 0 (0) | 0 (0) | ‐ |
| Revascularization, n (%) | 1 (1.4) | 1 (1.3) | 1.000 |
| Stroke, n (%) | 7 (9.9) | 5 (6.3) | 0.413 |
| Heart failure, n (%) | 5 (7.0) | 4 (5.0) | 0.735 |
| Angina‐related rehospitalization, n (%) | 12 (16.9) | 9 (11.3) | 0.316 |
Abbreviations: CMD, coronary microvascular dysfunction; INOCA, ischemia with no obstructive coronary arteries; MACE, major adverse cardiac events; MI, myocardial infarction.